Delft-based uPATCH, a health-tech startup, has secured seed funding from INZET, a fund managed by Shaping Impact Group, to further its mission of advancing global drug delivery through microneedle technology. The funding amount, however, remains undisclosed.
uPATCH specialises in developing applicators for microneedle array patches, aiming to make drug delivery more accessible worldwide.
“The team is on a mission to contribute to the future of vaccine administration and (re-) distribution; a mission closely aligned with our impact investing goals,” says Jelena Jakulj, Partner at Shaping Impact Group.
Making drug delivery available for everyone
Microneedles are a new drug delivery method recognised by the World Health Organisation (WHO) for their benefits over traditional needles. They are painless, require less medication, can be self-administered, and don’t need cold storage. However, microneedles can be less effective if not applied correctly.
To address this, uPATCH is developing applicators that help ensure microneedles work reliably.
Founded in 2018 by Koen van der Maaden and Bart van Oorschot, uPATCH aims to make microneedle use more consistent. Now based in Leiden BioScience Park, the company partners with other microneedle firms to improve this technology.
Capital utilisation
The funding will enable uPATCH to speed up product development, expand internationally, grow partnerships, enhance research and development, and establish an ISO13485 quality management system for a sustainable business.
Paul Bromberg, CEO of uPATCH, says, “This investment is a crucial milestone for uPATCH as we continue our mission to make drugs and vaccines accessible to everyone on earth.”
“Shaping Impact Group’s vision for supporting impactful innovation aligns perfectly with our goals, and their backing will accelerate our efforts to unlock the potential of microneedles.”
Brief about Shaping Impact Group
Shaping Impact Group is an impact-focused VC fund aiming to maximise societal returns by directing capital towards positive social and environmental outcomes.
The group supports impact investors and philanthropists through investment funds, consulting services, and fostering an impact-driven community. Its INZET fund specifically invests in social enterprises that enhance the quality of life for people needing care or help prevent chronic health issues.
